NCT06877416View on ClinicalTrials.gov

Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer

RecruitingOBSERVATIONAL

Enrollment

700

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 1, 2026

Study Completion Date

January 31, 2026

Conditions

Antibody-drug ConjugatesHER2-low Breast CancerBreast Neoplasms

Interventions

OTHER

Non-intervention research

Non-intervention research

Trial Locations (1)

510060

RECRUITING

Sun yat-sen University Cancer, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER